Table 3.
Follow-up of moderate (4–6 mm) and deep pockets (≥ 7 mm) detected at baseline and pocket closure at 3- and 12- months follow up
| 3 months | 12 months | |
|---|---|---|
| Follow-up of moderate pockets detected at baseline (%) | ||
| PPD ≤ 3 mm | ||
| Probiotic group (n = 16) | 68.5 ± 16.4 | 80.3 ± 18.3 |
| Antibiotic group (n = 16) | 74.0 ± 13.7 | 77.8 ± 18.9 |
| Placebo group (n = 15) | 77.0 ± 14.7 | 77.2 ± 14.5 |
| p value (inter-group) | 0.2877 | 0.6950 |
| PPD 4–6 mm | ||
| Probiotic group (n = 16) | 30.3 ± 15.9 | 18.8 ± 17.6 |
| Antibiotic group (n = 16) | 25.6 ± 13.0 | 20.9 ± 17.1 |
| Placebo group (n = 15) | 21.5 ± 13.1 | 21.5 ± 13.4 |
| p value (inter-group) | 0.2391 | 0.7886 |
| PPD ≥ 7 mm | ||
| Probiotic group (n = 16) | 1.2 ± 2.0 | 0.9 ± 2.3 |
| Antibiotic group (n = 16) | 0.4 ± 1.4 | 1.3 ± 2.6 |
| Placebo group (n = 15) | 1.5 ± 3.8 | 1.3 ± 3.8 |
| p value (inter-group) | 0.2861 | 0.8539 |
| Follow-up of deep pockets detected at baseline (%) | ||
| PPD ≤ 3 mm | ||
| Probiotic group (n = 16) | 16.5 ± 28.5 | 42.4 ± 41.3 |
| Antibiotic group (n = 16) | 33.0 ± 39.9 | 41.7 ± 43.9 |
| Placebo group (n = 15) | 43.3 ± 38.7 | 38.8 ± 31.5 |
| p value (inter-group) | 0.2087 | 0.9798 |
| PPD 4–6 mm | ||
| Probiotic group (n = 16) | 73.4 ± 30.9 | 47.0 ± 43.6 |
| Antibiotic group (n = 16) | 50.2 ± 37.3 | 50.0 ± 41.6 |
| Placebo group (n = 15) | 38.1 ± 28.1 | 45.9 ± 28.6 |
| p value (inter-group) | 0.1019 | 0.9715 |
| PPD ≥ 7 mm | ||
| Probiotic group (n = 16) | 10.1 ± 17.7 | 10.6 ± 18.2 |
| Antibiotic group (n = 16) | 16.8 ± 21.1 | 8.3 ± 18.0 |
| Placebo group (n = 15) | 18.6 ± 26.6 | 15.3 ± 16.3 |
| p value (inter-group) | 0.6924 | 0.3030 |
| Pocket closure (%) | ||
| Probiotic group (n = 16) | 65.3 ± 17.9 | 78.1 ± 20.0 |
| Antibiotic group (n = 16) | 71.9 ± 14.4 | 76.7 ± 19.7 |
| Placebo group (n = 15) | 73.3 ± 18.1 | 74.4 ± 16.8 |
| p value (inter-group) | 0.3790 | 0.6660 |
Data presented as mean ± SD. PPD probing pocket depth
Inter-group comparison by ANOVA and Kruskal Wallis test (p < 0.05)